Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03223493 · ClinicalTrials.gov registry record
Awareness, Care & Treatment in Obesity Management (ACTION) Study
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 3,767
- Enrollment target
NCT03223493 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 3,767 participants.
The verdict
NCT03223493 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 3,767 participants
- Enrollment target
Study Summary
The ACTION (Awareness, Care, and Treatment In Obesity management) study aims to identify perceptions, attitudes, behaviours, and potential barriers to effective obesity care across three respondent types: 1) People with Obesity, 2) Healthcare Providers and 3) Employer Representatives in the US. Data is collected via online surveys using a cross-sectional, US-based stratified sample design.
Interventions
- OTHER No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,767 participants |
| Start Date | 2015-10-29 |
| Est. Completion | 2015-11-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03223493
The ClinicalTrials.gov registry entry for NCT03223493 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,767 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No treatment given is the first listed.
NCT03223493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03223493 about?
NCT03223493 is a clinical study titled "Awareness, Care & Treatment in Obesity Management (ACTION) Study". The ACTION (Awareness, Care, and Treatment In Obesity management) study aims to identify perceptions, attitudes, behaviours, and potential barriers to effective obesity care across three respondent types: 1) People with Obesity, 2) Healthcare Providers and 3) Employer Representatives in the US. Data...
What is the current status of trial NCT03223493?
This trial is currently completed. The enrollment target is 3,767 participants. The study started on 2015-10-29. Estimated completion is 2015-11-12.
What interventions are being tested in trial NCT03223493?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT03223493?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.